Epidermal growth factor receptor (EGFR) polymorphisms and survival in head and neck cancer patients
- 1 August 2007
- journal article
- Published by Elsevier in Oral Oncology
- Vol. 43 (7) , 713-719
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Individualizing chemotherapeutic treatment of colorectal cancerAmerican Journal of Health-System Pharmacy, 2006
- Serum IgE, Tumor Epidermal Growth Factor Receptor Expression, and Inherited Polymorphisms Associated with Glioma SurvivalCancer Research, 2006
- Treatment of non-small-cell lung cancer and pharmacogenomics: where we are and where we are goingCurrent Opinion in Oncology, 2006
- Targeting Molecular Determinants of Tumor Chemo-RadioresistanceSeminars in Oncology, 2005
- Phase II Multicenter Study of the Epidermal Growth Factor Receptor Antibody Cetuximab and Cisplatin for Recurrent and Refractory Squamous Cell Carcinoma of the Head and NeckJournal of Clinical Oncology, 2005
- Analysis of the dinucleotide repeat polymorphism in the epidermal growth factor receptor (EGFR) gene in head and neck cancer patientsAnnals of Oncology, 2005
- Molecular therapy of head and neck cancerCancer and Metastasis Reviews, 2005
- An Epidermal Growth Factor Receptor Intron 1 Polymorphism Mediates Response to Epidermal Growth Factor Receptor InhibitorsCancer Research, 2004
- Epidermal growth factor receptor and tumor response to radiation: in vivo preclinical studiesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2004
- Sprouty2 Inhibits the Ras/MAP Kinase Pathway by Inhibiting the Activation of RafJournal of Biological Chemistry, 2002